Doctors Note Logo

Published on: 9/13/2026

Could fatigue and diarrhea together be a sign of cancer or Crohn's?

Fatigue paired with diarrhea can occasionally signal Crohn's disease or colorectal cancer, but these symptoms far more commonly point to infections, irritable bowel syndrome, celiac disease, thyroid problems, medication side effects, or food intolerances. Features that raise concern for a serious cause include blood in the stool, unexplained weight loss, fever, night sweats, anemia, diarrhea that wakes you at night, and symptoms persisting beyond two to four weeks. Your age, family history, and pain pattern also change how worrying the combination is, so there are several important factors to consider below before drawing conclusions.

Because fatigue and diarrhea overlap across dozens of conditions ranging from harmless to serious, guessing rarely helps and often adds anxiety. Take a free, instant, online symptom check to see which possibilities best match your specific pattern and understand what to do next.

Last reviewed for medical accuracy: 09/13/2026

answer background

Explanation

Fatigue and Diarrhea: Common Symptoms with Many Causes
Experiencing fatigue and diarrhea together can be unsettling. Both symptoms are common and often point to mild, self-limiting issues like a stomach bug or temporary stress. However, when they persist, it’s natural to wonder if something more serious—such as Crohn’s disease or even cancer—could be at play. This guide explains when you might worry, what other clues to watch for, and what steps to take next.

Possible Causes of Fatigue and Diarrhea

Most cases of fatigue and diarrhea are not cancer or Crohn’s. Common causes include:

  • Viral or bacterial infections (gastroenteritis)
  • Food intolerances (lactose, fructose)
  • Medications (antibiotics, antacids with magnesium)
  • Stress and anxiety
  • Irritable bowel syndrome (IBS)
  • Traveler’s diarrhea

If symptoms are brief (a few days) and improve with rest, hydration, and bland foods, they’re usually not serious. But when fatigue and diarrhea continue for weeks or months, further evaluation is wise.

When to Consider Crohn’s Disease

Crohn’s disease is an inflammatory bowel disease (IBD) that can affect any part of the digestive tract. Fatigue and diarrhea are hallmark symptoms, but other signs often appear too. Watch for:

  • Abdominal pain or cramping, often in the lower right abdomen
  • Blood in the stool or mucus
  • Unintended weight loss
  • Reduced appetite
  • Fever or night sweats
  • Mouth sores or joint pain

Crohn’s tends to strike younger adults (teens to 30s), but it can occur at any age. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), chronic inflammation in Crohn’s can impair nutrient absorption, leading to anemia and fatigue.

When to Consider Cancer

Fatigue and diarrhea can also be warning signs of colorectal cancer or, less commonly, other gastrointestinal cancers. Key “red flag” features include:

  • Age over 50 (or younger with a family history)
  • Persistent diarrhea lasting more than four weeks
  • Rectal bleeding or dark tarry stools
  • Iron-deficiency anemia causing severe fatigue
  • Unexplained weight loss (more than 5% of body weight)
  • Change in bowel habits (narrower stools, urgency, tenesmus)

The American Cancer Society notes that colorectal cancer often develops slowly, and early stages may not cause pain. That’s why spotting subtle changes matters.

Distinguishing Between Crohn’s and Cancer

Because Crohn’s and colorectal cancer share some symptoms, differentiating them can be challenging without medical testing. Here are some pointers:

  • Age of onset
    • Crohn’s: often younger (teens–30s)
    • Cancer: risk rises after age 50
  • Pattern of symptoms
    • Crohn’s: intermittent flares, accompanied by mouth ulcers or joint pain
    • Cancer: gradually worsening symptoms, persistent blood in stool
  • Family history
    • Crohn’s: autoimmune link, may run in families
    • Cancer: strong familial risk if close relatives are affected
  • Response to treatment
    • Crohn’s: may improve with anti-inflammatory medications
    • Cancer: will not resolve without surgical or oncologic intervention

Only tests—blood work, stool studies, colonoscopy with biopsy, imaging—can confirm either diagnosis.

Other Conditions to Consider

Before jumping to Crohn’s or cancer, your doctor may evaluate for:

  • Celiac disease – an autoimmune reaction to gluten
  • Microscopic colitis – inflammation seen only under a microscope
  • Small intestinal bacterial overgrowth (SIBO)
  • Pancreatic insufficiency
  • Thyroid disorders

Each of these can cause malabsorption, diarrhea, and tiredness.

When to Seek Medical Help

You should speak to a doctor if you have fatigue and diarrhea plus any of the following:

  • Symptoms lasting longer than two weeks
  • High fever (above 100.4°F/38°C)
  • Bloody or black, tarry stools
  • Severe abdominal pain or distension
  • Signs of dehydration (lightheadedness, dry mouth, low urine output)
  • Weight loss without trying

Early evaluation can detect serious issues sooner and improve outcomes.

What to Expect at the Doctor’s Office

Your healthcare provider may recommend:

  • Blood tests (complete blood count, inflammation markers)
  • Stool tests (infection, blood, fat content)
  • Imaging (CT scan, MRI, ultrasound)
  • Endoscopic exams (colonoscopy or upper endoscopy)

Based on results, you may be referred to a gastroenterologist for specialized care.

Managing Fatigue and Diarrhea at Home

While awaiting a diagnosis or alongside treatment, these steps can help:

  • Stay hydrated with water, electrolyte solutions, or broths
  • Eat small, bland meals (bananas, rice, applesauce, toast)
  • Avoid high-fat, spicy, or dairy foods if they worsen symptoms
  • Rest and pace yourself; fatigue often improves as diarrhea resolves
  • Consider probiotics, but discuss with your doctor first

Keep a symptom diary noting foods, stool frequency, energy levels, and any new signs.

Use a Free Symptom Checker as a First Step

If you’re unsure where to start, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s designed by clinicians to help you understand possible causes of your fatigue and diarrhea and direct you toward appropriate care.

Final Thoughts and Next Steps

Fatigue and diarrhea together most often signal a mild, treatable condition—but persistent or severe symptoms should never be ignored. Crohn’s disease and colorectal cancer are less common causes but can present similarly. Early detection and treatment matter.

If anything you experience feels life-threatening or seriously concerning, please speak to a doctor right away. Your healthcare team can guide testing, diagnosis, and treatment tailored to your needs. Taking action today can help you find answers and regain your health.

(References)

  • * Gryboski JD. Chronic diarrhea. Curr Probl Pediatr. 1979 Mar;9(5):1-52. doi: 10.1016/s0045-9380(79)80017-1. PMID: 436445; PMCID: PMC7131527.

  • * Wilkes G. Antiemetic agents. Oncology (Williston Park). 2007 Jul;21(8 Suppl):48. PMID: 17844897.

  • * Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT, NAPOLI-1 Study Group. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet. 2016 Feb 6;387(10018):545-557. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29. PMID: 26615328.

  • * Burger JA, Tedeschi A, Barr PM, Robak T, Owen C, Ghia P, Bairey O, Hillmen P, Bartlett NL, Li J, Simpson D, Grosicki S, Devereux S, McCarthy H, Coutre S, Quach H, Gaidano G, Maslyak Z, Stevens DA, Janssens A, Offner F, Mayer J, O'Dwyer M, Hellmann A, Schuh A, Siddiqi T, Polliack A, Tam CS, Suri D, Cheng M, Clow F, Styles L, James DF, Kipps TJ, RESONATE-2 Investigators. Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med. 2015 Dec 17;373(25):2425-37. doi: 10.1056/NEJMoa1509388. Epub 2015 Dec 6. PMID: 26639149; PMCID: PMC4722809.

  • * Feuerstein JD, Cheifetz AS. Crohn Disease: Epidemiology, Diagnosis, and Management. Mayo Clin Proc. 2017 Jul;92(7):1088-1103. doi: 10.1016/j.mayocp.2017.04.010. Epub 2017 Jun 7. PMID: 28601423.

  • * Corn PG, Heath EI, Zurita A, Ramesh N, Xiao L, Sei E, Li-Ning-Tapia E, Tu SM, Subudhi SK, Wang J, Wang X, Efstathiou E, Thompson TC, Troncoso P, Navin N, Logothetis CJ, Aparicio AM. Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1-2 trial. Lancet Oncol. 2019 Oct;20(10):1432-1443. doi: 10.1016/S1470-2045(19)30408-5. Epub 2019 Sep 9. PMID: 31515154; PMCID: PMC6858999.

  • * Parigi TL, Bonifacio C, Danese S. Is It Crohn's Disease? Gastroenterology. 2020 Oct;159(4):1244-1246. doi: 10.1053/j.gastro.2020.04.066. Epub 2020 May 1. PMID: 32371110; PMCID: PMC7194052.

  • * Diaz LA Jr, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fourchardiere C, Rivera F, Elez E, Le DT, Yoshino T, Zhong WY, Fogelman D, Marinello P, Andre T, KEYNOTE-177 Investigators. Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study. Lancet Oncol. 2022 May;23(5):659-670. doi: 10.1016/S1470-2045(22)00197-8. Epub 2022 Apr 12. PMID: 35427471; PMCID: PMC9533375.

  • * Chan JA, Geyer S, Zemla T, Knopp MV, Behr S, Pulsipher S, Ou FS, Dueck AC, Acoba J, Shergill A, Wolin EM, Halfdanarson TR, Konda B, Trikalinos NA, Tawfik B, Raj N, Shaheen S, Vijayvergia N, Dasari A, Strosberg JR, Kohn EC, Kulke MH, O'Reilly EM, Meyerhardt JA. Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13;392(7):653-665. doi: 10.1056/NEJMoa2403991. Epub 2024 Sep 16. PMID: 39282913; PMCID: PMC11821447.

  • * Schram AM, Goto K, Kim DW, Macarulla T, Hollebecque A, O'Reilly EM, Ou SI, Rodon J, Rha SY, Nishino K, Duruisseaux M, Park JO, Neuzillet C, Liu SV, Weinberg BA, Cleary JM, Calvo E, Umemoto K, Nagasaka M, Springfeld C, Bekaii-Saab T, O'Kane GM, Opdam F, Reiss KA, Joe AK, Wasserman E, Stalbovskaya V, Ford J, Adeyemi S, Jain L, Jauhari S, Drilon A, eNRGy Investigators. Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer. N Engl J Med. 2025 Feb 6;392(6):566-576. doi: 10.1056/NEJMoa2405008. PMID: 39908431; PMCID: PMC11878197.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.